This is a preview of subscription content, log in via an institution to check access.
Notes
2015 US dollars
Reference
Mo X, et al. Cost-Effectiveness and Health Benefits of Pediatric 23-Valent Pneumococcal Polysaccharide Vaccine, 7-Valent and Forecasting 13-Valent Pneumococcal Conjugate Vaccines in China. Pediatric Infectious Disease Journal : 24 Jun 2016. Available from: URL: http://doi.org/10.1097/INF.0000000000001288
Rights and permissions
About this article
Cite this article
PCV-13 has greatest benefit but not cost effective in China. PharmacoEcon Outcomes News 757, 24 (2016). https://doi.org/10.1007/s40274-016-3213-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3213-z